U.S. Medical Foods Market Size, Growth and Forecast 2034

U.S. Medical Foods Market Growth, Size, Trends Analysis - By Product, By Route of Administration, By Application, By Sales Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Q: How can I get a sample report on the U.S. Medical Foods Market?

You can get the sample pages by clicking the link - Click Here

Published: Aug-2025	Report ID: HLCA25256	Pages: 1 - 154	Formats^*:
Category : Healthcare

U.S. Medical Foods Market Introduction and Overview

According to SPER Market Research, the U.S. Medical Foods Market is estimated to reach USD 11.58 billion by 2034 with a CAGR of 5.85%.

The report includes an in-depth analysis of the U.S. Medical Foods Market, including market size and trends, product mix, Applications, and supplier analysis. The estimated size of the U.S. medical foods market was USD 6.56 billion in 2024, with a projected growth rate of 5.85% CAGR from 2025 to 2034. The rising incidence of conditions such as Parkinsonâ€™s disease, epilepsy, cancer, and kidney diseases, among others, has led to a significant demand for medical food products from healthcare professionals. The increasing occurrence of these targeted disorders, coupled with advancements in drug development within the country, is propelling the need for disease-specific formulas in healthcare facilities and various end-use sectors.

By Product Insights:

In 2024, the powdered form of medical foods generated the largest revenue. These products are easily mixed with water or milk for oral or enteral administration and are suitable for all age groups. Increased consumer preference for powdered products has prompted manufacturers to develop more options. The liquid medical food segment is projected to grow the fastest through 2034, particularly for patients with difficulty swallowing or those unable to consume solid food.

By Route of Administration Insights:

The oral route of administration was the most significant segment in 2024, with widespread use of nutrient and vitamin supplements in healthcare institutions. Oral supplements are available in various forms, such as liquids, powders, pills, and other types. The enteral route, which includes specially formulated feeding formulas for different demographic groups, is expected to grow rapidly.

By Application Insights:

In 2024, the cancer segment led the U. S. medical food market, driven by the high prevalence of the disease and its associated nutritional challenges. Around 40%-80% of cancer patients experience malnutrition, increasing the demand for medical foods designed to restore nutrition. The Parkinson's disease segment is expected to grow quickly as well, with some medical foods offering potential benefits despite the absence of specific dietary treatments.

By Sales Channel Insights:

Institutional sales accounted for the largest revenue share in 2024, primarily from long-term care centers, hospitals, and other healthcare facilities. Healthcare professionals significantly influence purchasing decisions, as medical food consumption is usually supervised. This sector is likely to expand with more healthcare institutions and an increasing number of chronic disease patients. Meanwhile, online sales are anticipated to grow the fastest from 2025 to 2034, with manufacturers increasingly utilizing e-commerce for direct sales to customers. The convenience of buying medical food online is driving this trend, and as more people prefer this method, it creates new opportunities for companies in the market.

Regional Insights:

The Northeast region has taken the lead in the U.S. Medical Foods Market, attributed to its robust healthcare infrastructure, a significant number of hospitals and research facilities, and an increased awareness of clinical nutrition. Additionally, the aging demographic in this region, along with a higher incidence of chronic illnesses, further fuels the demand for medical foods, thereby fostering steady market growth and innovation.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape:

Prominent companies engaged in the development of medical food products include Danone, NestlÃ©, Abbott, and Fresenius Kabi. These firms are primarily concentrating on launching new products to enhance their revenue and expand their geographical reach. Danone, which is based in France, is a prominent global food corporation operating through four business segments: fresh dairy products, waters, early life nutrition, and advanced medical nutrition. The company has a North American division with its headquarters in New York, as well as an innovation and technology center located in Colorado. Danone provides a variety of products across the tube feeds, oral feeds, pediatric, and metabolic categories.

Recent Developments:

In April 2024, Brain Ritual, a wellness brand based in Switzerland, announced the introduction of the medical food product MigraKet, designed to tackle the underlying causes of migraines. This product was developed by Elena Gross, PhD, a renowned neuroscientist and former chronic migraine sufferer, and has been made available to customers in the United States.

In January 2024, Abbott launched the PROTALITY brand, introducing a high-protein nutrition shake for adults aiming to lose weight while preserving nutrition and muscle mass. This shake contains a blend of slow- and fast-digesting protein, feeding muscles for up to 7 hours, along with essential B vitamins, comfort fiber, and various minerals and vitamins.

Scope of the report:

Report Metric	Details
Market size available for years	2021-2034
Base year considered	2024
Forecast period	2025-2034
Segments covered	By Product, By Route of Administration, By Application, By Sales Channel
Regions covered	Northeast, Midwest, West, South.
Companies Covered	Danone North America Public Benefit Corporation, NestlÃ©, Abbott, Targeted Medical Pharma, Inc, Fresenius Kabi AG, Primus Pharmaceuticals, Inc, Mead Johnson & Company, LLC, Metagenics, Alfasigma USA, Inc.

Key Topics Covered in the Report:

U.S. Medical Foods Market Size (FY 2021-FY 2034)
Overview of U.S. Medical Foods Market
Segmentation of U.S. Medical Foods by Product (Powder, Pills, Liquid, Other)
Segmentation of U.S. Medical Foods Market by Route of Administration (Oral, Enteral)
Segmentation of U.S. Medical Foods Market by Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases)
Segmentation of U.S. Medical Foods Market by Sales Channel (Online Sales, Retail Sales, Institutional Sales)
Statistical Snap of U.S. Medical Foods Market
Expansion Analysis of U.S. Medical Foods Market
Problems and Obstacles in U.S. Medical Foods Market
Competitive Landscape in the U.S. Medical Foods Market
Details on Current Investment in U.S. Medical Foods Market
Competitive Analysis of U.S. Medical Foods Market
Prominent Players in the U.S. Medical Foods Market
SWOT Analysis of U.S. Medical Foods Market
U.S. Medical Foods Market Future Outlook and Projections (FY 2025-FY 2034)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTERs Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. U.S. Medical Foods Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S. Medical Foods Market

7. U.S. Medical Foods Market, By Product (USD Million) 2021-2034

7.1. Powder
7.2. Pills
7.3. Liquid
7.4. Other

8. U.S. Medical Foods Market, By Route of Administration (USD Million) 2021-2034

8.1. Oral
8.2. Enteral

9. U.S. Medical Foods Market, By Application (USD Million) 2021-2034

9.1. Chronic Kidney Disease
9.2. Minimal Hepatic Encephalopathy
9.3. Chemotherapy Induced Diarrhoea
9.4. Pathogen Related Infections
9.5. Diabetic Neuropathy
9.6. ADHD
9.7. Depression
9.8. Alzheimer's Disease
9.9. Nutritional Deficiency
9.10. Orphan Diseases
9.11. Cancer

10. U.S. Medical Foods Market, By Sales Channel (USD Million) 2021-2034

10.1. Online Sales
10.2. Retail Sales
10.3. Institutional Sales

11. U.S. Medical Foods Market, (USD Million) 2021-2034

11.1. U.S. Medical Foods Market Size and Market Share

12. U.S. Medical Foods Market, By Region (USD Million) 2021-2034

12.1. Northeast
12.2. Midwest
12.3. West
12.4. South

13. Company Profile

13.1. Danone North America Public Benefit Corporation

13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments

13.2. NestlÃ©

13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments

13.3. Abbott

13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments

13.4. Targeted Medical Pharma, Inc

13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments

13.5. Fresenius Kabi AG

13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments

13.6. Primus Pharmaceuticals, Inc

13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments

13.7. Mead Johnson & Company, LLC

13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments

13.8. Metagenics

13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments

13.9. Alfasigma USA, Inc

13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments

13.10. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the U.S. Medical Foods Market?

U.S. Medical Foods Market is projected to reach USD 11.58 billion by 2034, growing at a CAGR of of 5.85% during the forecast period.

What is the growth rate of the U.S. Medical Foods Market?

U.S. Medical Foods Market grew in Market size from 2025. The Market is expected to reach USD 11.58 billion by 2034, at a CAGR of 5.85% during the forecast period.

What is the anticipated CAGR of the U.S. Medical Foods Market?

U.S. Medical Foods Market CAGR of 5.85% during the forecast period.

How can I get a sample report on the U.S. Medical Foods Market?

You can get the sample pages by clicking the link - Click Here

What is the Market size of the U.S. Medical Foods Market?

U.S. Medical Foods Market size is USD 11.58 billion from 2025 to 2034.

Which segment is expected to U.S. Medical Foods Market?

U.S. Medical Foods Market is covered By Product, By Route of Administration, By Application, By Sales Channel

Which region is expected to have the highest Market share in the U.S. Medical Foods Market?

The Northeast, Midwest, West, South. is the highest Market share in the U.S. Medical Foods Market.

Who are the key players in U.S. Medical Foods Market?

Danone North America Public Benefit Corporation, Nestlé, Abbott, Targeted Medical Pharma, Inc, Fresenius Kabi AG, Primus Pharmaceuticals, Inc, Mead Johnson & Company, LLC, Metagenics, Alfasigma USA, Inc.

What is the conclusion of the U.S. Medical Foods Market?

The report includes an in-depth analysis of the U.S. Medical Foods Market, including market size and trends, product mix, Applications, and supplier analysis.